ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · IEX Real-Time Price · USD
1.59
-0.05 (-3.06%)
Nov 30, 2023, 11:57 AM EST - Market open
ImmunoPrecise Antibodies Stock Forecast
IPA's stock price has decreased by -67.5% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for IPA stock stock is $8.00, which predicts an increase of 404.73%. The lowest target is $7.00 and the highest is $9.00. On average, analysts rate IPA stock stock as a strong buy.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 18, 2023.
Analyst Ratings
The average analyst rating for IPA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +467.82% | Sep 18, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +467.82% | Jul 12, 2023 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +341.64% | Jul 11, 2023 |
| Benchmark | Benchmark | Buy Maintains $12 → $7 | Buy | Maintains | $12 → $7 | +341.64% | Mar 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +467.82% | Mar 17, 2023 |
Financial Forecast
Revenue This Year
24.16M
from 20.67M
Increased by 16.90%
Revenue Next Year
28.41M
from 24.16M
Increased by 17.61%
EPS This Year
-0.52
from -1.07
EPS Next Year
-0.34
from -0.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.2M | 29.5M | 35.5M | 42.1M | 50.0M |
| Avg | 24.2M | 28.4M | 34.1M | 40.5M | 48.1M |
| Low | 23.3M | 27.6M | 33.1M | 39.3M | 46.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.1% | 22.3% | 24.9% | 23.3% | 23.4% |
| Avg | 16.9% | 17.6% | 20.2% | 18.6% | 18.7% |
| Low | 12.9% | 14.1% | 16.6% | 15.1% | 15.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.49 | -0.36 | -0.20 | - | 0.21 |
| Avg | -0.52 | -0.34 | -0.20 | - | 0.20 |
| Low | -0.54 | -0.33 | -0.19 | - | 0.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.